Venn Life Sciences secures first skin science patent
19th Jun 2014 07:21
Clinical research organisation Venn Life Sciences announced its innovation division Innoven has secured its first skin patent for its anti-acne complex from the European Patent Office. The patent is expected to reduce bacteria, inflammation, and excess oiliness in less than four hours and will be r
Read moreRightmove Chairman sells 7m pounds of shares
27th May 2014 15:09
Rightmove's Chairman Scott Forbes has offloaded nearly a half of a holding in the property website group, selling over seven million pounds in shares. Forbes, who has been in his current role since 2005, sold 300,000 shares at an average price of 2,350.81p each, raising a total of £7.05m. Followin
Read moreVenn Life Sciences scores multi-million euro contract
16th May 2014 12:56
AIM-listed clinical research organisation Venn Life Sciences announced it has scored a multi-million euro contract with a major European biotechnology company. The agreement, which is spread out over a year and a half and spans over seven European countries as well as a number of US sites, will see
Read moreVenn Life Sciences wins new contracts
26th Apr 2013 15:11
Venn Life Sciences has won two contracts to provide a number of clinical trial-management services across Europe. The first contract is with a global pharmaceutical company to conduct a Phase IV drug interaction study and the second is with a leading US biotech company to manage a multi-national st
Read moreVenn Life Sciences sets up Russian arm
7th Feb 2013 11:12
Clinical research company Venn Life Sciences on Thursday said it expanded its operations with a new Russian business. The group has established Venn Russia, a joint venture with a local contract research organisation (CRO). The new arm will operate from offices in Moscow and will complement exist
Read more